Last Updated: Monday, November 4, 2013, 17:41
Country's largest drug maker Dr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.
Last Updated: Thursday, October 31, 2013, 15:54
Drug major Dr Reddy's Laboratories today reported a 69.41 percent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
Last Updated: Friday, September 27, 2013, 12:21
United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.
Last Updated: Thursday, August 22, 2013, 18:25
The drug was supplied to three different parties with three different brand names.
Last Updated: Tuesday, July 30, 2013, 16:33
Drug maker Dr Reddy's Laboratories Tuesday said its net profit rose by over seven percent to Rs 361 crore for the quarter ended June 30, primarily driven by North American revenues.
Last Updated: Sunday, July 14, 2013, 15:04
In a filing with US Securities and Exchange Commission, DRL also said some of the provisions of European Falsified Medicines Directive may cause delayed exports to European Union.
Last Updated: Wednesday, June 26, 2013, 18:31
The approval is for the product in the strengths of 25 mg, 50 mg, 100 mg, 200 mg and 300 mg, it added.
Last Updated: Wednesday, June 19, 2013, 11:23
US-based drug maker AbbVie Inc, the spun-off entity of Abbott, has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six counts concerning three patents.
Last Updated: Tuesday, June 4, 2013, 19:19
Pharma stocks led by Apollo Hospitals, Cadila Health and Dr Reddy's Lab Tuesday gained as much as 5.5 percent on value-buying in an otherwise weak stock market.
Last Updated: Monday, June 3, 2013, 13:47
Though the Memorandum of Understanding for generic drugs has been cancelled, both the companies will explore partnerships in other related areas, said a statement issued by DRL.
Last Updated: Tuesday, May 14, 2013, 16:23
Drug firm Dr Reddy's Laboratories on Tuesday reported a 66.58 percent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013 mainly on account of robust sales across all segments.
Last Updated: Monday, May 13, 2013, 18:53
Life Insurance Corporation (LIC) sold 2.13 percent stake in Dr Reddy's Laboratories from January 10 to May 10 through open market, according to a BSE filing by DRL.
more videos >>
